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Background: C5a and its cognate receptor, C5a receptor (C5aR), key elements of complement, are critical
modulators of liver immunity and fibrosis. However, the molecular mechanism for the cross talk between
complement and liver fibrosis is not well understood. C5a is a potent chemokine regulating migration of cells in
the innate immune system. Since activation and migration of hepatic stellate cells (HSC) are hallmarks of liver
fibrosis, we hypothesized that C5a contributes to fibrosis by regulating HSC activation and/or migration.
Results: Primary cultures of mouse HSC increased expression of alpha smooth muscle actin (α-SMA) and collagen
1A (Col1A1) mRNA in response to activation on plastic. Expression of mRNA for C5aR, but not C5L2, a second C5a
receptor that acts as a negative regulator, increased in parallel with markers of HSC activation in culture. Increased
expression of C5aR on activated HSC was confirmed by immunocytochemistry. Cell surface expression of C5aR was
also detected by flow cytometry on activated HSC isolated from mice expressing GFP under the control of the
collagen promoter after exposure to chronic carbon tetrachloride. To understand the functional significance of
C5aR expression in HSC, we next investigated whether C5a influenced HSC activation and/or migration. Challenge
of HSC with C5a during culture had no effect on expression of α-SMA and Col1A1, suggesting that C5a did not
influence HSC activation. Another important characteristic of HSC is their migratory capacity; migration of HSC in
response to platelet derived growth factor (PDGF) and monocyte chemoattractant protein-1 (MCP-1) has been well
characterized. Challenge of HSC with C5a enhanced HSC migration almost as efficiently as PDGF in a two-dimensional
wound healing and Boyden chamber migration assays. C5a also stimulated expression of MCP-1. C5a-induced cell
migration was slowed, but not completely inhibited, in presence of 227016, a MCP-1 receptor antagonist, suggesting
C5a-induced migration occurs via both MCP-1-dependent and -independent mechanisms.
Conclusions: These data reveal that C5a regulates migration of HSC and suggest a novel mechanism by which
complement contributes to hepatic fibrosis. C5a and its receptors are therefore potential therapeutic targets for the
prevention and/or treatment of liver fibrosis.
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Hepatic stellate cells (HSC), also known as Ito cells or
lipocytes, are the major cell type contributing to liver fi-
brosis. HSC constitute about 2% to 6% of the total cell
population in the liver and are located in the space of
Disse, between hepatocytes and sinusoidal endothelial
cells. In a healthy liver, HSC primarily function in the* Correspondence: nagyL3@ccf.org
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unless otherwise stated.homeostasis of vitamin A [1]. However, upon activation
under conditions of liver injury, HSC lose their vitamin A
deposits and transform into a myofibroblast-like phenotype,
characterized by the expression α-smooth muscle actin
(α-SMA) and collagen [2]. Activation of HSC is a hallmark
of the wound healing response leading to accumulation
of extracellular matrix, scar formation, and fibrosis
[3,4]. Interestingly, there is a growing body of evidence
that HSC exhibit a number of characteristics typical of
cells in the innate immune system, including active
phagocytosis [5,6], expression of Toll-like receptors [7],
and components of the inflammasome [8]. However, our
understanding of the function for these innate immune. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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incomplete.
Complement, comprised of a large number of distinct
plasma proteins, as well as membrane-bound receptors and
regulatory proteins, is a critical component of the innate
immune system that provides links to adaptive immunity
[9]. Proteolysis of C5 is one of the key events of comple-
ment activation, generating the small cleavage fragment,
C5a. C5a, an anaphylatoxin, induces or amplifies multiple
innate immune responses. C5a exerts most of its functions
through interaction with its cognate receptor, C5a receptor
(C5aR) [10]. However, an emerging body of evidence in-
dicates the involvement of a second C5a receptor, C5L2,
which acts as a negative modulator of C5aR activity
[11,12]. C5aR and C5L2 share significant homology in
structure [13] and are expressed on macrophages, dendritic
cells, and neutrophils [14]. C5a binding to C5aR induces
rapid auto-phosphorylation, internalization, and subsequent
signalling leading to acute inflammatory responses and
chemotaxis [11,12].
Recent studies have identified complement as an import-
ant contributor to a variety of liver disorders such as viral
hepatitis, alcoholic liver disease, non-alcoholic steatohepa-
titis, and liver fibrosis [15]. C5 is identified as a quantitative
trait gene in mouse and human that contributes to hepatic
fibrosis across species [16]. However, the molecular and
cellular mechanisms by which C5 contributes to fibrosis
have not been well studied. Complement is dynamically ac-
tivated in response to carbon tetrachloride (CCl4)-induced
liver fibrosis [17]. Complement activation products gener-
ated in response to fibrotic insults are known to be in-
volved in both the priming of hepatocytes for regeneration
and the clearance of cellular debris. However, much less is
known about the possible role of C5a and its cognate re-
ceptors in the regulation of HSC. In one report, challenge
of LX2 cells, an immortalized human stellate cell line, with
C5a increased expression of α-SMA and collagen [18].
Here we have investigated the interaction of complement
with primary cultures of murine HSC, interrogating the
ability of C5a to mediate activation and migration of HSC.
We find that C5a receptors, C5aR and C5L2, are expressed
upon HSC activation both in culture and in vivo. Challenge
of primary cultures of murine HSC with C5a did not influ-
ence their activation state; however, C5a potently stimu-
lated migration of HSC. Taken together these data suggest
that interaction of C5a and its receptor are important
contributors to the migration of activated HSC and thus
contribute to the progression of hepatic fibrosis.
Results
Expression of mRNA for complement receptors during
activation of primary HSC in culture
Activation of primary HSC during culture is associated
with increased expression of α-SMA (Figure 1A) andcollagen1A1 (Col1A1) (Figure 1B) [19]. If complement
activation products are important regulators of HSC
function in the context of hepatic fibrosis, then HSC
should express complement receptors. While expression
of C3aR, C5aR, and C5L2 was low in quiescent HSC, ex-
pression of mRNA for both C3aR and C5aR, but not C5L2,
increased in parallel with α-SMA and Col1A1 mRNA from
day 2 to day 10 in culture (Figure 1C). Increased expression
of immunoreactive C5aR, assessed by confocal imaging,
was detected during HSC activation from day 5 to day 10
(Figure 1D), paralleling the rise in C5aR mRNA expression
during HSC activation.
Activated HSC isolated from mice treated with CCl4
express C5aR and C5L2
While the phenotype of primary HSC activated in cul-
ture typically models the phenotype of HSC activated
in the liver in response to fibrotic insult, it is critical to
validate results of cell culture experiments with data
from HSC activated in vivo. To check expression of
C5a receptors in HSC activated in vivo, transgenic
mice expressing GFP under the regulation of the colla-
gen promoter [20] were injected with CCl4 twice
weekly over a period of 5 weeks to induce fibrosis. Flow
cytometric analysis was performed on the total non-
parenchymal cell population isolated from these mice.
The population of cells positive for GFP-fluorescent
protein, indicating an activated, collagen-producing
phenotype, also expressed C5aR and C5L2 on their cell
surface (Figure 2).
C5a did not enhance the activation of primary HSC in culture
To understand if C5a contributed to the activation of
primary HSC during culture, mid-quiescent primary
HSC (day 5) were treated with or without 10 ng/mL C5a
until day 8. While culture from days 5 to 8 increased ex-
pression of α-SMA and Col1A1 mRNA, addition of C5a
did not influence expression of these markers of HSC
activation (Figure 3A and B). Further, treatment of HSC
with C5a had no effect on the expression of either C5aR
(Figure 3C) or C5L2 (data not shown) mRNA.
C5a enhanced HSC migration in two-dimensional wound
healing and Boyden chamber cell migration assays
Upon activation, HSC synthesize chemokines that facilitate
migration of infiltrating immune cells, as well as additional
HSC, into the site of injury [21]. Since C5a exhibits chemo-
tactic properties [22], we tested whether C5a modulated
migration of activated HSC in a two-dimensional wound
healing assay. The effect of C5a on HSC migration was
compared to that mediated by platelet derived growth
factor (PDGF), a potent modulator of HSC migration.
Wound closure in untreated cells reached 40% to 60%
by 10 h and 24 h, respectively, after injury (Figure 4A, B).
Figure 1 Activation of HSC induced expression of C3aR and C5aR, but not C5L2. Primary HSC were isolated from C57BL/6 mice and grown
in culture. Expression of (A) α-SMA and (B) collagen1A1 and (C) C3aR, C5aR, and C5L2 mRNA was measured by qRT-PCR and normalized to 18S.
Values represent means ± SEM, N = 5. (A/B) Values with different superscripts are significantly different from each other (P <0.05). (C) *P <0.05
compared to day 2. (D) Confocal immunocytochemistry for C5aR protein expression was assessed in HSC on day 5 and 10 of culture. C5aR
(green) and DAPI (blue). Images are representative of three independent HSC isolations.
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of wound healing both at 10 h and 24 h, with wound
healing completed by 24 h after injury. Cells treated
with 50 ng/mL PDGF exhibited rapid wound healing,
with complete cellular coverage of the injury by 10 h
(Figure 4A, B). PDGF and C5a, under the conditions of
this experiment, did not have an additive effect. Similarly,
even when lower concentrations of C5a (5 ng/mL) and
PDGF (25 ng/mL) were tested, PDGF and C5a did not
have additive effects on migration (data not shown).
Results from the two-dimensional wound healing assay
were then confirmed in a standard Boyden chamber mi-
gration assay. HSC migration was increased by 1.5-foldFigure 2 CCl4-induced fibrosis was associated with expression of C5a
control of the collagen promoter were exposed to CCl4 for 5 weeks to gen
Cells were stained with anti-C5aR and anti-C5L2 (PE) and gated for GFP anupon treatment with 10 ng/mL C5a (Figure 4C). PDGF
treatment stimulated HSC migration approximately two-
fold and, as in the two-dimensional assay, the chemotac-
tic activity of C5a and PDGF were not additive under
these conditions (Figure 4C).
Role for MCP-1 in C5a-stimulated migration in response
to injury in primary HSC
C5a has direct and potent chemotactic activity, but in
other cell types, such as macrophages, C5a also increases
the expression of MCP-1, another potent chemokine [23].
Consistent with this previous data in macrophages,
when primary mid-quiescent HSC (day 5 in culture)R/C5L2 on activated HSC. Transgenic mice expressing GFP under the
erate fibrosis. Total NPC were isolated and analyzed by flow cytometry.
d PE. Images are representative of three independent HSC isolations.
Figure 3 C5a did not affect HSC activation or expression of
C5aR and C5L2. Mid-quiescent cells (day 5 in culture) were treated
or not with C5a (10 ng/mL). Expression of (A) α-SMA, (B) Collagen1A1
and (C) C5aR mRNA was measured by qRT-PCR and normalized to 18S.
Values represent means ± SEM, N = 4. Values with different superscripts
are significantly different from each other (P <0.05).
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mRNA increased by six-fold (Figure 5). Based on these
data, we hypothesized that C5a may enhance the migra-
tion of HSC in response to injury via direct and/or
indirect mechanisms. To understand the role of MCP-1
in C5a-mediated chemotaxis, a CCR2 (MCP-1 receptor)
antagonist (227016) was used in the wound healing
assay. While the CCR2 antagonist had no effect on the
rate of wound healing in non-treated HSC, it delayed
the wound healing response in cells treated with C5a
or PDGF (Figure 6A,B). MCP-1 receptor antagonist
decreased the rate of C5a-mediated cell migration;
even after 24 h, complete healing did not occur. The
rate of cell migration was also slowed in cells treated
with PDGF in presence of CCR2 antagonist; however,
PDGF-treated cells were completely restored by 24 h
even in the presence of antagonist (Figure 6).
Discussion
Complement, a critical component of the innate immune
system, has been implicated in the progression of a var-
iety of liver diseases, particularly related to hepatic fi-
brosis [15]. Importantly, genetic studies have identified
a role for C5 in fibrotic responses in multiple tissues, in
both humans and mice [16]. However, the mechanism
by which C5 contributes to fibrosis is not well studied.
Here we identified for the first time that activated primary
HSC express both C5aR and C5L2. C5aR expression
was increased both at the level of mRNA and protein.
While C5a did not influence the activation of primary
HSC during culture, C5a was a potent chemotactic stimu-
lus to activated HSC, assessed in both two-dimensional
wound healing and Boyden chamber cell migration assays.
The chemotactic activity of C5a on HSC was due, at least
in part, to an increase in the expression of MCP-1, an-
other chemokine that potently stimulates HSC migra-
tion. Importantly, these data point to the potential for
both C5aR and chemokine receptor antagonists, such as
the CCR2 antagonist 227016, as therapeutic agents for
the prevention and/or treatment of fibrosis.
C5a acts primarily through its receptor C5aR. C5aR
belongs to the G-protein coupled receptor (GPCR) family
and is expressed in a wide range of cell and tissue types
including brain, liver, and adipocytes. C5aR comprises
of seven trans-membrane domain and upon binding to
C5a results in activation of the heterotrimeric guanine
nucleotide-binding proteins or G-proteins, which ultimately
Figure 4 C5a enhanced HSC chemotaxis. HSC on day 8 of culture were used in a two-dimensional wound healing assay (A, B). Cells were
treated or not with C5a (10 ng/mL) and/or PDGF (50 ng/mL). Images were captured at 0 h, 10 h, and 24 h. Gap width and rate of wound healing
were analyzed with Wimasis image analysis software. (C) Boyden chamber chemotaxis: On day 8 of culture, HSC were serum starved for 18 h,
then detached and resuspended in serum-free DMEM. Inserts containing cells were immersed in serum-free DMEM with or without 10 ng/mL
C5a, 50 ng/mL PDGF or both. Chemotaxis was assessed after 10 h incubation, as described in Methods. Values represent means ± SEM, N = 3 for
wound healing assay, N = 5 for boyden chamber chemotaxis assay. Values with different superscripts are significantly different from each other.
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(cAMP) and calcium mitogen-activated protein (MAP)
kinases [12]. C5L2 or GPR77 is the second receptor for
C5a also reported to have seven transmembrane do-
mains but uncoupled from G-proteins [24]. C5aR and
C5L2 are expressed by inflammatory cells, dendritic
cells, macrophages, lymphocytes, and monocytes, as
well as a wide range of cells in liver, lung, kidney, and
heart, under specific physiological conditions [11,12].
Here we report for the first time that activated HSC
express both C5aR and C5L2; expression of C5aR, but
not C5L2, increased in activated compared to quiescent
HSC. There is growing appreciation that HSC express
multiple receptors and pathways that are typically con-
sidered to be part of innate immune responses, includ-
ing expression of TLRs and inflammasome components
[7,8]. These data add a sensitivity to complement to this
growing list of innate immune competencies expressed
by HSC.Activation of HSC is regulated by a complex yet co-
ordinated set of transcription factors, including NFκB,
AP-1, C/EBP, PPAR, Kruppel like transcription factors
and E-box transcription factors [25]. C5a receptor sig-
nals via multiple pathways, including cAMP, MAPKs,
and PI3K/AKT-dependent signalling [12]. In macro-
phages, C5a also stimulates the activation of C/EBPβ
and C/EBPδ [26]. Given the complex signalling events
initiated with C5a agonism, we first tested the ability of
C5a to increase activation of HSC in culture on plastic, as
well as the regulation of expression of Col1A1 mRNA.
C5a did not modulate the activation of primary cultures
of HSC, nor increase Col1A1 expression (Figure 1). This
is similar to a previous report that C5a induced fibro-
nectin in primary rat HSC but failed to induce collagen
or α-SMA [27], but contrasts with another study that
reported C5a increased both α-SMA and collagen in
LX2 cells, an immortalized human stellate cell line [18].
The difference between these data is likely due to the
Figure 5 C5a induces MCP-1 mRNA in HSC. Primary HSC on day
5 of culture were treated or not with C5a (10 ng/mL). MCP-1 mRNA
level was measured by qRT-PCR and normalized to 18S. Values
represent means ± SEM, N = 4. Values with different superscripts are
significantly different from each other.
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primary HSC on plastic [28] as compared to the mid-
quiescent like phenotypic stability of the LX2 cell line.
While C5a did not modulate activation of primary
HSC culture on plastic, it did have a potent stimulatory
effect on HSC migration in a two-dimensional wound
healing assay and in the Boyden chamber cell migration
assay. This response is consistent with the strong chemo-
tactic activity of C5a on other cell types [12]. The impact
of C5a on HSC migration was nearly as robust as PDGF,
known to be a potent stimulus for HSC migration. MCP-1
is another important chemokine which is upregulated
upon HSC activation and implicated in the progression
of hepatic fibrosis. C5a induces MCP-1 expression in a
number of cell types [29-31]; stimulation of MCP-1 ex-
pression, as well as other cytokines and chemokines, is
considered to be a mechanism by which C5a amplifies
inflammatory responses. While the pathway by which
C5a increases MCP-1 expression is not well understood,
it is dependent on C5a receptor-mediated activation of
AKT in RAW 264.7 macrophages [23] and is mediated
at a pre-translational level in other cells of the innate
immune system [29]. Consistent with these previous re-
ports of C5a-stimulated MCP-1 expression in other cell
types, C5a also induced expression of MCP-1 mRNA in
activated HSC. Taken together, these data demonstrate
that C5a has potent chemotactic effects on HSC that are
both dependent and independent of MCP-1. During the
fibrotic response in the liver, recruitment of immune
cells to the site of injury is equally as important as the
recruitment of HSC. Since C5a has chemoattractanteffects on both immune cells [12] and HSC (Figure 4),
it is likely that C5a contributes via multiple pathways to
the progression of hepatic fibrosis.
Conclusions
Taken together, these data demonstrate for the first time
that the anaphylatoxin C5a modulates migration of HSC,
a key cell type involved in hepatic fibrosis. This work links
two important aspects in the generation and progression
of fibrosis, complement, and HSC. HSC, activated both
in culture and in vivo, expressed both C5aR and C5L2;
expression of C5aR increased with activation of HSC
in culture. Although activation of primary HSC was
not affected in response to challenge with C5a, HSC
migration was enhanced in the presence of C5a. C5a
also induced expression of MCP-1 mRNA in HSC and
antagonism of the MCP-1 receptor (CCR2) partially
inhibited HSC migration. These data add complement
to the growing list of innate immune activities that are
observed in activated HSC and provide insights into
possible therapeutic regulation of complement in the
prevention and/or treatment of liver fibrosis.
Methods
Materials
Female C57BL/6 mice were purchased from Jackson
Laboratory. Recombinant Mouse Complement Component
(C5a) was procured from R & D Systems (Minneapolis,
MN, USA). Cell culture reagents were from Invitrogen
(Grand Island, NY, USA). Hank’s balanced salt solution
(HBSS) and PBS were purchased from Media Core (CCF,
Cleveland, OH, USA). Common reagents were from Sigma
Aldrich unless mentioned otherwise.
Hepatic stellate cell isolation and culture
All procedures involving animals were approved by
the Cleveland Clinic Institutional Animal Care and
Use Committee. Adult mice (aged 20 to 36 weeks old)
were anesthetized and livers from three mice finely
minced in a sterile petri-dish. Minced liver was enzy-
matically processed in Hank’s balanced salt solution
(HBSS) containing pronase (7.5 mg/mL) and collage-
nase (2 mg/mL) for 30 m at 37°C. Liver digests were
then centrifuged at 50 g for 2 m to pellet hepatocytes.
Supernatant was collected and centrifuged for 7 m at
1,500 g to collect non-parenchymal cells (NPC). Total
NPCs were then re-suspended in HBBS containing
DNaseI (0.26 mg/mL) and centrifuged for 6 m at 1,500 g.
Hepatic stellate cells were purified from the total NPCs
by centrifugation on a histodenz gradient [32]. HSC
were checked for retinyl ester deposits in presence of
UV light on day 2 of culture; approximately 70% to 80%
of cells contained retinyl ester deposits. Purified HSC
was cultured in DMEM media, supplemented with 10%
Figure 6 Antagonism of the MCP-1 receptor (CCR2) slowed C5a mediated HSC migration. HSC on day 8 of culture were used in a
two-dimensional wound healing assay (A,B). Cells were pre-treated with or without a CCR2 receptor antagonist, 227016 (10 nM), for 30 min and
then challenged with C5a (10 ng/mL) and/or PDGF (50 ng/mL). Images were captured at 0 h, 10 h, and 24 h following stimulation. Gap width
was analyzed by Wimasis image analysis software. Values represent means ± SEM, N = 4. Values with different superscripts are significantly different
from each other.
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fungizone (PSF). Cells from day 2, day 5, and day 10 in
culture were used to isolate RNA and synthesize cDNA.
To understand the effect of C5a on HSC activation and
complement receptor expression, day 5 HSC were treated
or not with C5a (10 ng/mL in HSC culture media) and
cultured for 72 h.
Quantitative real-time PCR
Total RNA was isolated using RNeasy micro kit (Qiagen)
according to manufacturer’s instructions. RNA (200 ng)
was reverse transcribed using the RETRO script kit
(Ambion). qRT-PCR was performed in an MX3000p
(Stratagene, La Jolla, CA, USA) using Brilliant II SYBR
Green qRT-PCR master mix (Cat# 600828, Agilent
Technologies, USA). Primers used for qRT-PCR wassynthesized by Integrated DNA Technologies (Coralville,
IA, USA). Details of all the primer sequences used are
provided in Table 1. Statistical analysis of qRT-PCR data
was performed using ΔCT values.
Migration assay
Primary HSC at day 8 were trypsinized and plated within
the cell culture inserts (Cat no# 80209, ibidi, Munich,
Germany) placed in a 24 well plate (0.25 x 106/chamber).
When cells formed confluent tight monolayer, they were
serum starved for 24 h to arrest them in G0 phase. Inserts
were then carefully removed, resulting in a gap of approxi-
mately 500 nm between the two monolayers. Cells were
washed twice with sterile PBS and then cultured in DMEM
media (10% heat inactivated FBS, 1% PSF) with or without
recombinant mouse C5a (10 ng/mL), mouse PDGF-BB
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tration of C5a was chosen based on physiologically
relevant concentrations observed in liver [27,18] and
preliminary experiments testing a range of concentra-
tions from 5 to 30 ng/mL C5a. Maximal stimulation of
migration was observed at 10 ng/mL (data not shown).
In the experiment with CCR2 (MCP-1 receptor) antag-
onist (227016, Millipore), 227016 (10 nM) was added
to the cell media 30 min prior to treatment with PDGF
or C5a. Images were captured using Olympus IX81
Microscope at 0, 10, and 24 h. Gap width and rate of
wound healing was analyzed using Wimasis Image ana-
lysis software (Munich, Germany).
Boyden chamber chemotaxis assay
Boyden chambers were used to assess HSC chemotaxis
using the QCM 5 um Chemotaxis assay kit from Millipore
(Cat # ECM506), per manufacturer instructions. Briefly,
primary HSC at day 8 were serum-starved in DMEM with
0.5% FBS for 18 h. HSCs were then washed twice with 1X
PBS and detached using Accutase cell detachment solu-
tion (BD Pharmingen). Cells were counted and suspended
in serum-free DMEM (0.3 × 106/mL) and 250 uL of the
cell suspension added into each insert. A total of 500 uL
of serum-free DMEM, with or without C5a or PDGF, was
then added to the lower chamber. After incubation at
37°C for 10 h, inserts were stained, washed, and destained
and optical density measured at 560 nm. Cells from the
upper membrane layer were removed prior to destaining
in order to decrease non-specific background staining.
Flow cytometry
To study HSC activated in vivo, transgenic mice with GFP
tagged to the collagen promoter were injected with carbontetrachloride (CCl4) for 5 weeks (two injection/week, one
dose 0.25 μL/g body weight, one dose of 0.5 μL/g body
weight, and eight doses of 1.0 μL/g body weight). Total
non-parenchymal cells (NPC) were isolated and immedi-
ately used for staining. Cells were centrifuged at 800Xg for
4 min; pellet was washed with 1X PBS and re-suspended
in 50 μL of FACS buffer (1% BSA, 0.1% sodium azide in
1X PBS). Cells were blocked with 1.0 μg of anti-mouse
CD32/CD16 FCγ receptor blocking antibody for 15 min
at 4°C. Cells were then stained with 1.5 μg C5aR (CD88)
and 0.5 μg C5L2 phycoerythrin-conjugated primary anti-
body or isotype control (phycoerythrin-conjugated IgG1)
diluted in FACS buffer and for 30 min at 4°C. Cells
were centrifuged at 800Xg for 4 min, washed once with
FACS buffer, and re-suspended in 50 μL fixing buffer
(1% paraformaldehyde in 1X PBS). Stained cells are kept in
the dark at 4°C overnight, following which they were centri-
fuged at 830 × g for 4 min. Stained cells were suspended in
300 uL of FACS buffer, and data were collected on a LSRII
flow cytometer (Becton Dickinson Immunocytometry
systems, Mountain View, CA, USA). Data collected on the
LSRII were analysed using FlowJo software (Tree Star,
Inc., Ashland, OR, USA).
Immunocytochemistry
Primary HSC (day 5 and day 10 of culture) were detached
from their growth plates and re-seeded in an 8-well cham-
ber slide (Nagle Nunc International, Rochester, NY) at a
density of 1.0 × 106 cells/mL, 0.5 mL/well. After overnight
incubation (to allow complete attachment of cells and re-
covery from trypsinization), cells were washed with ice-cold
1X PBS and fixed with 4% paraformaldehyde for 10 min at
room temperature (0.5 mL/well). Cells were washed with
25 mM glycine (two times, 1 min each, 0.5 mL/well),
followed by two washes in PBS (1 min each, 0.5 mL/well).
Cells were blocked with 1X PBS containing 1% fish gelatin
containing 2% BSA and 0.1% Triton-X-100 for 1 h and
incubated overnight with polyclonal mouse C5aR anti-
body (diluted 1:25 in blocking buffer without Triton-X)
at 4°C in a humidified chamber. After three washes in
PBS buffer (3 times 10 min each), cells were incubated
with the fluorochrome-conjugated secondary antibody
(Alexa fluor 488 labelled goat-anti-rabbit IgG, 1:50 diluted
in blocking buffer without Triton X) for 1 h at room
temperature. Cells were then washed three times in
PBS and mounted with VECTASHIELD 1200 (with DAPI).
A slide without primary antibody was used as negative
control. Fluorescence images were acquired using a
LEICA DMRXE confocal microscope.
Statistical analysis
Values are reported as means ± standard error of the
means (SEM). Data were analyzed by analysis of vari-
ance (ANOVA) using general linear models procedure
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